Compartir
Información de la revista
Número
Vol. 29. Núm. 4.(julio - agosto 2024)
Editorial
Liver fibrosis: More than meets the eye
Amedeo Lonardo
Ann Hepatol. 2024;29:101479
Acceso a texto completo
Opinions
Key points for imaging diagnosis and response assessment for hepatocellular carcinoma in Latin America
Federico Diaz Telli, Juan Manuel Perez Hidalgo, Adriana Varón, Lorena Castro, Norberto Chavez Tapia, Federico Piñero
Ann Hepatol. 2024;29:101514
Acceso a texto completo
Original articles
Retinopathy as a predictive indicator for significant hepatic fibrosis according to T2DM status: A cross-sectional study based on the national health and nutrition examination survey data
Jinze Li, Yi Xiang, Jiahao Han, Youfang Gao, Ruiying Wang, Zihe Dong, Huihui Chen, Ruixia Gao, ... Xiaolong Qi
Ann Hepatol. 2024;29:101478
Acceso a texto completo
Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
Ankoor H. Patel, Gaurav N. Pathak, Alexander Chen, Patricia Greenberg, Natale Mazzaferro, Anish Patel, Naveen Mallangada, Carlos D. Minacapelli, ... Vinod K. Rustgi
Ann Hepatol. 2024;29:101510
Acceso a texto completo
Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis
Luis Vega, Daniela Simian, Abraham I. Gajardo, Marcelo Salinas, Andrea Urra, Máximo Cattaneo, Rosario Pino, Juan P. Roblero, ... Jaime Poniachik
Ann Hepatol. 2024;29:101511
Acceso a texto completo
Impact of preoperative nonselective beta-blocker use on acute kidney injury after living donor liver transplantation: Propensity score analysis
Hye-Won Jeong, Jae Hwan Kim, Sang-bin Han, Hye-Mee Kwon, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang
Ann Hepatol. 2024;29:101474
Acceso a texto completo
Genome-wide DNA methylation and transcriptomic analysis of liver tissues subjected to early ischemia/reperfusion injury upon human liver transplantation
Pablo J. Giraudi, Allen A. Laraño, Simeone Dal Monego, Riccardo Pravisani, Deborah Bonazza, Gabriel Gondolesi, Claudio Tiribelli, Francisco Baralle, ... Danilo Licastro
Ann Hepatol. 2024;29:101506
Acceso a texto completo
Utilizing a novel MRI technique to identify adverse muscle composition in end-stage liver disease: A pilot study
Avesh J. Thuluvath, Mikael F. Forsgren, Daniela P. Ladner, Amit D. Tevar, Andres Duarte-Rojo
Ann Hepatol. 2024;29:101508
Acceso a texto completo
ZBP1 promotes hepatocyte pyroptosis in acute liver injury by regulating the PGAM5/ROS pathway
Shengguang Yan, Lina Yu, Ziren Chen, Dan Xie, Zuli Huang, Shi Ouyang
Ann Hepatol. 2024;29:101475
Acceso a texto completo
Efficacy and safety of terlipressin and albumin vs. noradrenaline and albumin in adult patients with hepatorenal syndrome: A systematic review and meta-analysis
Adnan Malik, Muhammad Imran Malik, Shahbaz Qureshi, Abdul Nadir
Ann Hepatol. 2024;29:101495
Acceso a texto completo
Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis
Ludmila Resende Guedes, Guilherme Grossi Lopes Cançado, Bruno Campos Santos, Luma dos Santos Jacomassi, Mateus Jorge Nardelli, Fernanda Maria Farage Osório, Luciana Costa Faria, Cláudia Alves Couto
Ann Hepatol. 2024;29:101497
Acceso a texto completo
Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis?
Luciana Agoglia, Ana Carolina Cardoso, Lívia Barbosa, Cecília Schubert Xavier Lagalhard Victer, Sueli Carneiro, Paulo Henrique Condeixa de França, Maria Chiara Chindamo, Cristiane Alves Villela-Nogueira
Ann Hepatol. 2024;29:101477
Acceso a texto completo
Prognostic significance of low hepatic fat content in advanced chronic liver disease: MRI-PDFF insights
Atsushi Nakamura, Tsubasa Yoshimura, Takeshi Ichikawa, Keiji Okuyama
Ann Hepatol. 2024;29:101507
Acceso a texto completo
Brief report
Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021
Stephen E. Congly, Mayur Brahmania, Carla S. Coffin
Ann Hepatol. 2024;29:101509
Acceso a texto completo
Letters to the editor
From NAFLD to MASLD: Promise and pitfalls of a new definition
Kenneth Cusi, Zobair Younossi, Michael Roden
Ann Hepatol. 2024;29:101179
Acceso a texto completo
Reply to: “From NAFLD to MASLD: Promise and pitfalls of a new definition’
Mary E. Rinella, Graciela E.Castro Narro, Aleksander Krag, Norah Terrault, Philip N. Newsome
Ann Hepatol. 2024;29:101178
Acceso a texto completo
Correspondence: “A multisociety Delphi consensus statement on new fatty liver disease nomenclature”
Kim Sui Wan, Wah-Kheong Chan, Muhammad Fadhli Mohd Yusoff, Feisul Mustapha, Halizah Mat Rifin, Kishwen Kanna Yoga Ratnam, Noor Ani Ahmad
Ann Hepatol. 2024;29:101485
Acceso a texto completo
Protean strictures: Shifting severity beneath the diagnostic façade
Fateh Bazerbachi, Najib Nassani, Klaus Mönkemüller
Ann Hepatol. 2024;29:101513
Acceso a texto completo
Hot topics in hepatology a multinational perspective
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
Francisco Barrera, Javier Uribe, Nixa Olvares, Paula Huerta, Daniel Cabrera, Manuel Romero-Gómez
Ann Hepatol. 2024;29:101501
Acceso a texto completo
Publique en
Annals of Hepatology
Affiliated societies
